| Sep 3 |
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
|
| Sep 1 |
TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching
|
| Aug 27 |
AngioDynamics (ANGO) Upgraded to Strong Buy: Here's Why
|
| Aug 18 |
With 83% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns
|
| Aug 15 |
AngioDynamics (ANGO) Down 3.1% Since Last Earnings Report: Can It Rebound?
|
| Aug 15 |
Accuray's (ARAY) Radixact for Cancer Treatment Debuts in US
|
| Aug 14 |
Does AngioDynamics (ANGO) Have the Potential to Rally 77.03% as Wall Street Analysts Expect?
|
| Aug 1 |
Should You Buy AngioDynamics (ANGO) After Golden Cross?
|
| Jul 29 |
AngioDynamics to Participate in Upcoming Investor Conferences
|
| Jul 29 |
Wall Street Analysts Predict a 74.25% Upside in AngioDynamics (ANGO): Here's What You Should Know
|
